Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: AbbVie Adds Neuroscience Heft With Syndesi Acquisition

Mar 01 2022

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Content

From Iran To The US: From Scientist To Entrepreneur

May 24 2021

ANI Partners With Oakrum For First US Generic Of Cystadane

Feb 16 2022

Kabi Brings In Reddy’s Rituximab As Biosimilar Breakeven Date Retreats

Feb 23 2022

Ipsen To Exit Consumer Health And Focus On Specialty Pharma

Feb 11 2022

Pfizer Shopping For Deals That Will Add $25bn To 2030 Revenues

Feb 09 2022

Biohaven Returns To Well With Bristol License, Acquires Channel Biosciences

Feb 25 2022

Biocon’s $3.3bn Biosimilars Big Leap Also Marks Viatris’ 'Smart' Exit, Albeit Toehold

Feb 28 2022

High-Flying Biotech Valuations Are Falling – And Maybe That’s A Good Thing

Feb 24 2022

Intellia Broadens Its Oncology Bets With CRISPR-Edited NK Cell Therapies

Feb 16 2022

Big Pharma Deal Hunters Target RNA Approaches In Race To Build Best Platforms

Feb 21 2022

Collegium, BioDelivery To Combine Pain Portfolios In Proposed Merger

Feb 14 2022

Curve Inks Mammoth Deal With MSD Just Three Years After $6.1m Seed Funding

Feb 17 2022

J&J Jumps On RNA-Based Small Molecules Train In Pact With Remix

Feb 17 2022

Deal-Making Attitudes Begin To Shift As Funding Options Decline

Feb 24 2022

AbbVie Buys In On Morphic’s Oral Integrin Inhibitors, To Tune Of $100m

Oct 18 2018

Yselty For Uterine Fibroids Edges Closer To Being Obseva’s First Commercial Product

Jul 06 2020

Allergan Exits <em>Noctiva</em> Partnership With Serenity Just As FDA Approves Controversial Drug

Mar 07 2017

Deal Watch: BridgeBio To Launch New Subsidiary Around Rare Disease Candidate Obtained From Alexion

Jun 18 2018

UCB Spinout Syndesi Brings New Approach To Dementia

Apr 15 2018

ImmunoGen banks $20M up front in Lilly antibody-drug conjugate deal

Dec 21 2011

Ovid Shifts Focus After Angelman Syndrome Drug Disappoints In Phase III

Dec 02 2020

Related Companies

AbbVie Inc.

Syndesi Therapeutics SA

UCB S.A.

BioNTech SE

Medigene AG

Blueprint Medicines Corporation

Roivant Sciences Ltd.

Acerus Pharmaceuticals Corporation

Serenity Pharmaceuticals LLC

Eli Lilly and Company

ImmunoGen, Inc.

Grifols, S.A.

Equillium, Inc.

Bioniz Therapeutics, Inc.

Roche Holding AG

Aquinnah Pharmaceuticals, Inc.

ObsEva SA

Theramex SPA

Healx

Ovid Therapeutics, Inc.

Merck & Co., Inc.

H. Lundbeck A/S

Serotiny

Tessera Therapeutics

Grupo Ferrer Internacional, S.A.

United Therapeutics Corporation

Morphic Therapeutic, Inc.

Cyclerion Therapeutics, Inc.

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window